본문 바로가기
KERD
논문KCI 등재

Constructing a Real-Time Prescription Drug Monitoring System

1

조회

0

다운로드

3

인용

0

참고문헌

키워드

초록

Objectives: The objective of this investigation was to demonstrate the possibility of the construction of a real-time prescription drug monitoring system (PDMOS) using data from the nationwide Drug Utilization Review (DUR) system in Korea. Methods: The DUR system collects information on drug prescriptions issued by healthcare practitioners and on drugs dispensed by pharmacies. PDMOS was constructed using this data. The screen of PDMOS is designed to exhibit the number of drug prescriptions, the number of prescriptions dispensed by pharmacies, and the dispensed prescription drug costs on a daily and weekly basis. Data was sourced from the DUR system between June 1, 2016 and July 18, 2016. The TOGA solution developed by the EYEQMC Co. Ltd. of Seoul, Korea was used to produce the screen shots. Results: Prescription numbers by medical facilities were more numerous than the number of prescriptions dispensed by pharmacies, as expected. The number of prescriptions per day was between 2 to 3 million. The prescriptions issued by primary care clinics were most numerous, at 75% of the total number of prescriptions. Daily prescription drug costs were found to be approximately US $50 million. The prescription drug costs were highest on Mondays and were reduced towards the end of the week. Prescriptions and dispensed prescriptions numbered approximately 1,200 and 1,000 million, respectively. Conclusions: The construction of a real-time PDMOS has been successful to provide daily and weekly information. There was a lag time of only one day at the national level in terms of information extraction, and scarcely any time was required to load the data. Therefore, this study highlights the potential of constructing a PDMOS to monitor the estimate the number of prescriptions and the resulting expenditures from prescriptions.

Abstract

Objectives: The objective of this investigation was to demonstrate the possibility of the construction of a real-time prescription drug monitoring system (PDMOS) using data from the nationwide Drug Utilization Review (DUR) system in Korea. Methods: The DUR system collects information on drug prescriptions issued by healthcare practitioners and on drugs dispensed by pharmacies. PDMOS was constructed using this data. The screen of PDMOS is designed to exhibit the number of drug prescriptions, the number of prescriptions dispensed by pharmacies, and the dispensed prescription drug costs on a daily and weekly basis. Data was sourced from the DUR system between June 1, 2016 and July 18, 2016. The TOGA solution developed by the EYEQMC Co. Ltd. of Seoul, Korea was used to produce the screen shots. Results: Prescription numbers by medical facilities were more numerous than the number of prescriptions dispensed by pharmacies, as expected. The number of prescriptions per day was between 2 to 3 million. The prescriptions issued by primary care clinics were most numerous, at 75% of the total number of prescriptions. Daily prescription drug costs were found to be approximately US $50 million. The prescription drug costs were highest on Mondays and were reduced towards the end of the week. Prescriptions and dispensed prescriptions numbered approximately 1,200 and 1,000 million, respectively. Conclusions: The construction of a real-time PDMOS has been successful to provide daily and weekly information. There was a lag time of only one day at the national level in terms of information extraction, and scarcely any time was required to load the data. Therefore, this study highlights the potential of constructing a PDMOS to monitor the estimate the number of prescriptions and the resulting expenditures from prescriptions.

참고문헌 (15)

  1. Health, United States, 2015: with special feature on racial and ethnic health disparities, "National Center for Health Statistics", National Center for Health Statistics, ~ (2016)
  2. 2015 National healthcare expenditure statistics, "Health Insurance Review and Assessment Service", Health Insurance Review and Assessment Service, ~ (2016)
  3. 신현철, "Healthcare Utilization Monitoring System in Korea", Healthcare Informatics Research, 21(3), pp.184~190 (2015), 대한의료정보학회[DOI]
  4. Peterson AM, "Managed care pharmacy practice", pp.215~232 (2008), Jones and Bartlett Publishers
  5. Prescription drugs: state monitoring programs provide useful tool to reduce diversion, "United States General Accounting Office", United States General Accounting Office, ~, pp.GAO-02-634 (2002)
  6. Reifler LM, "Do prescription monitoring programs impact state trends in opioid abuse", misuse?, 2012, pp.13(3), 434~442
  7. Clark T, "Prescription drug monitoring programs: an assessment of the evidence for best practices" (2012), Brandeis University
  8. Finklea K, "Prescription drug monitoring programs", J Drug Addict Educ Erad, 10(4), pp.481~505 (2014)
  9. Annual review of prescription monitoring programs, "National Alliance for Model State Drug Laws", National Alliance for Model State Drug Laws, ~ (2015)
  10. Hildebran C, "How clinicians use prescription drug monitoring programs: a qualitative inquiry", Pain Med, 15(7), pp.1179~1186 (2014)
  11. Hackman DT, "Prescription drug monitoring program inquiry in psychiatric assessment: detection of high rates of opioid prescribing to a dual diagnosis population", J Clin Psychiatry, 75(7), pp.750~756 (2014)
  12. Smith RJ, "How, why, and for whom do emergency medicine providers use prescription drug monitoring programs?", Pain Med, 16(6), pp.1122~1131 (2015)
  13. Ortiz E, "Use of information technology to improve the quality of health care in the United States", Health Serv Res, 38(2), pp.xi~xxii (2003)
  14. Girosi F, "Extrapolating evidence of health information technology savings and costs" (2005), RAND Corporation
  15. Fichman RG, "The role of information systems in healthcare: current research and future trends", Inf Syst Res, 22(3), pp.419~428 (2011)

관련 논문AI추천

The Effects after Implementing a Drug Utilization Review System on Contraindicated Drug use: A Systematic Review이희영, 지은희, 최혜숙한국임상약학회 · 한국임상약학회지2019 · 제29권 제1호New Alert Override Codes for the Drug Utilization Review System Derived from Outpatient Prescription Data from a Tertiary Teaching Hospital in Korea장철, 김우재, 박래웅, 박만영, 안은경, 유기봉대한의료정보학회 · Healthcare Informatics Research2016 · 제22권 제1호3차 의료기관에서 전산화의약품사용평가프로그램 설치 전후의 의약품처방 비교김상미, 손현순, 신현택한국임상약학회 · 한국임상약학회지2011 · 제21권 제1호The Development of a Korean Drug Dosing Database김선아, 김영훈, 김종훈, 김홍빈, 이병구, 이은경, 이은숙, 이인향, 장유진, 전만호, 전진옥, 정영미, 진호준, 최경숙, 하지혜, 황중운대한의료정보학회 · Healthcare Informatics Research2011 · 제17권 제4호DUR 제도 및 DUR 고도화 시범사업에 대한 인식 탐구: 포커스 그룹 인터뷰 기법 중심의 질적 연구배성호, 신주영, 윤동원, 이혜성, 전하림, 최아형한국임상약학회 · 한국임상약학회지2021 · 제31권 제2호건강보험심사청구 자료에 근거한 병용금기 약물의 후향적 약물사용평가 : 처방전 조제 형태별 분석신현택, 이영숙한국임상약학회 · 한국임상약학회지2011 · 제21권 제3호

이 간행물의 다른 논문 (12건)